ABBV
Abbvie Inc
Price:  
189.16 
USD
Volume:  
4,661,197.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Abbvie Relative Valuation

-73.1%
Upside

As of 2025-06-10, the Relative Valuation of Abbvie Inc (ABBV) is 50.82 USD. This relative valuation is based on P/E multiples. With the latest stock price at 189.16 USD, the upside of Abbvie Inc based on Relative Valuation is -73.1%.

The range of the Relative Valuation is 38.81 - 60.27 USD.

Range Selected
Trailing P/E multiples 19.0x - 25.4x 21.4x
Forward P/E multiples 16.4x - 24.3x 21.5x
Fair Price 38.81 - 60.27 50.82
Upside -79.5% - -68.1% -73.1%
189.16 USD
Stock Price
50.82 USD
Fair Price

Abbvie Relative Valuation - Historical P/E Data

Date P/E
2025-06-09 79.65
2025-06-06 79.93
2025-06-05 78.94
2025-06-04 78.88
2025-06-03 78.85
2025-06-02 78.74
2025-05-30 78.37
2025-05-29 78.16
2025-05-28 77.09
2025-05-27 78.20
2025-05-23 77.17
2025-05-22 76.86
2025-05-21 76.55
2025-05-20 77.84
2025-05-19 78.20
2025-05-16 77.49
2025-05-15 76.50
2025-05-14 74.72
2025-05-13 79.16
2025-05-12 80.03
2025-05-09 77.73
2025-05-08 78.14
2025-05-07 79.20
2025-05-06 78.80
2025-05-05 82.56
2025-05-02 83.57
2025-05-01 81.41
2025-04-30 82.15
2025-04-29 81.48
2025-04-28 80.99
2025-04-25 78.34
2025-04-24 75.95
2025-04-23 74.55
2025-04-22 73.17
2025-04-21 71.65
2025-04-17 72.84
2025-04-16 72.29
2025-04-15 74.45
2025-04-14 75.41
2025-04-11 73.71
2025-04-10 73.35
2025-04-09 75.73
2025-04-08 73.97
2025-04-07 78.55
2025-04-04 78.72
2025-04-03 84.91
2025-04-02 86.40
2025-04-01 86.85
2025-03-31 88.22
2025-03-28 86.44